News
06-01-2015, 02:30 AM
Caris Life Sciences, a leading biotechnology company focused on fulfilling the promise of precision medicine, today announced the presentation of data from three studies that demonstrate the utility of Caris Molecular Intelligence®, the company's panomic comprehensive tumor profiling service, in facilitating comparisons between tumors that share histological features.
More... (http://www.news-medical.net/news/20150601/Caris-Molecular-Intelligence-allows-comparisons-between-tumors-sharing-histological-features.aspx)
More... (http://www.news-medical.net/news/20150601/Caris-Molecular-Intelligence-allows-comparisons-between-tumors-sharing-histological-features.aspx)